Home › Compare › GNTTF vs BTI

GNTTF vs BTI: Dividend Comparison 2026

GNTTF yields 20000.00% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNTTF wins by $52481917574412746752.00M in total portfolio value
10 years
GNTTF
GNTTF
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full GNTTF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — GNTTF vs BTI

📍 GNTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNTTFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNTTF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GNTTF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNTTF
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, GNTTF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNTTF + BTI for your $10,000?

GNTTF: 50%BTI: 50%
100% BTI50/50100% GNTTF
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

GNTTF
No analyst data
Altman Z
-0.3
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNTTF buys
0
BTI buys
0
No recent congressional trades found for GNTTF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNTTFBTI
Forward yield20000.00% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$52481917574412746752.00M ✓$37.7K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$2,786.64
Total dividends collected$52448189483771600896.00M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: GNTTF vs BTI ($10,000, DRIP)

YearGNTTF PortfolioGNTTF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$2,010,700$2,000,000.00$11,299$598.92+$2.00M → GNTTF
2$377,983,225$375,831,775.70$12,794$703.91+$377.97M → GNTTF
3$66,433,479,469$66,029,037,418.28$14,518$829.07+$66433.46M → GNTTF
4$10,916,985,471,987$10,845,901,648,955.73$16,513$978.64+$10916985.46M → GNTTF
5$1,677,384,363,769,318$1,665,703,189,314,291.80$18,827$1,157.84+$1677384363.75M → GNTTF
6$240,985,175,079,139,100$239,190,373,809,905,920.00$21,518$1,373.12+$240985175079.12M → GNTTF
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$24,657$1,632.46+$32373573631143.67M → GNTTF
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$28,329$1,945.74+$4066766648320630.00M → GNTTF
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$32,637$2,325.33+$477730483406513344.00M → GNTTF
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$37,708$2,786.64+$52481917574412746752.00M → GNTTF

GNTTF vs BTI: Complete Analysis 2026

GNTTF — Stock

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin. Their platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs.

Full GNTTF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this GNTTF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNTTF vs SCHDGNTTF vs JEPIGNTTF vs OGNTTF vs KOGNTTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.